An analysis of diagnostic values of prognostic tools for communityacquired pneumonia in young patients in a closed community
https://doi.org/10.18093/0869-0189-2014-0-5-67-72
Abstract
Aim. One of the key issues of management of a patient with communityacquired pneumonia (CAP) is an adequate initial assessment of severity. This is especially important during CAP epidemic outbreaks among young patients in closed communities. Currently, several scales are used allowing a rational choice of a place of therapy on the basis of risk of poor outcome. These scales have advantages and disadvantages but they have not been studied in CAP patients in closed communities.
Methods. A comparative analysis of diagnostic values of CRB65 and SMRTCO scales in 274 young patients in closed communities was performed. Procalcitonin (PCT) and Creactive protein (CRP) were measured. Discriminative values of the
scales were estimated with the ROCanalysis.
Results. CRB65 and SMRTCO scores were significantly related to PCT level. The correlation between SMRTCO score and PCT was closer compared to correlation between CRB65 score and PCT.
Conclusion. The results have shown obvious perspectives in improvement SMRTCO score by adding PCT that could increase its sensitivity.
About the Authors
A. A. Zaytsev
Federal Institution Acad. N.N.Burdenko The Main Military Clinical Hospital; Moscow, Russia
Russian Federation
Russian Federation
Yu. V. Ovchinnikov
The Main Military Medical Department, Ministry of Defense of Russian Federation; Moscow, Russia
Russian Federation
Russian Federation
T. V. Kondrat'eva
Federal Institution Territorial Military Clinical Hospital N 1586; Podol'sk, Moscow region, Russia
Russian Federation
Russian Federation
References
1. Chuchalin A.G., Sinopal'nikov A.I., Kozlov R.S. et al. Communityacquired Pneumonia in Adults: Practical Guidelines on Diagnosis, Treatment and Prevention. Moscow; 2010 (in Russian).
2. Mandell L., Wunderink R., Anzueto A. et al. Infectious Diseases Society of America / American Thoracic Society Consensus Guidelines on the Management of Community – Acquired Pneumonia in Adults. Clin. Infect. Dis. 2007; 44 (2): 27–72.
3. Woodhead M., Blasi F., Ewig S. et al. Guidelines for the management of adult lower respiratory tract infections. Clin. Microbiol. Infect. 2011; 17 (6): 1–59.
4. Kuchmin A.N., Akimkin V.G., Sinopal'nikov A.I. et al. Diagnosis, Treatment and Prevention of Community Acquired Pneumonia in the Russian Military: Methodological Guidelines. Moscow: GVKG im. N.N.Burdenko; 2009 (in Russian).
5. Fine M., Auble T., Yealy D. et al. A prediction rule to identify lowrisk patients with communityacquired pneumonia. N. Engl. J. Med. 1997; 336 (4): 243–250.
6. Lim W., van der Eerden M., Laing R. et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003; 58 (5): 377–382.
7. Bauer T., Ewig S., Marre R. et al. CRB65 predicts death from communityacquired pneumonia. J. Intern. Med 2006; 260 (1): 93–101.
8. Charles P., Fine M., Ramirez J. et al. Validation of SMARTCOP: a pneumoniae severity assessment tool for predicting with patients will need intensive respiratory or inotropic support (IRIS). In: 47th ICAAC. Chicago; 2007: Abstr: L1156a.
9. Charles P., Wolfe R., Whitby M. et al. SMARTCOP: A tool for predicting the need for intensive respiratory or vasopres sor support in communityacquired pneumonia. Clin. Infect. Dis. 2008; 47 (3): 375–384.
10. Chalmers J., Singanayagam A., Hill A. Predicting the need for mechanical ventilation and / or inotropic support for young adults admitted to the hospital with community acquired pneumonia. Clin. Infect. Dis. 2008; 47 (12): 1571–1574.
11. Lim W., Baudouin S., George R., et al. Pneumonia Guidelines Committee of the BTS Standards of CareCommittee. BTS guidelines for the management of comunityacquired pneumonia in adults: update 2009. Thorax. 2009; 64: 1–55.
12. Spindler C., Ortqvist A. Prognostic score systems and communityacquired bacteraemic pneumococcal pneumonia. Eur. Respir. J. 2006; 28 (4): 816–823.
13. Fesenko O.V. Severe communityacquires pneumonia in young patients (diagnosis, clinical presentation, and treat ment): Diss. Moscow; 2005 (in Russian).
14. Aujesky D., Auble T., Yerly D., et al. Prospective comparison of three validated prediction rules for prognosis of communityacquired pneumonia. Am. J. Med. 2005; 118 (4):384–392.
15. Capelastegui A, Espana P.P., Quintana J.M., et al. Validation of a predictive rule for the management of communityacquired pneumonia. Eur. Respir. J. 2006; 27 (1):151–157.
16. Bauer T., Ewig S., Marre R. et al. CRB65 predicts death from communityacquired pneumonia. J. Intern. Med. 2006; 260 (1): 93–101.
17. Rudnov V.A., Fesenko A.A., Drozd A.V. A comparative analysis of diagnostic values of prognostic scales in patients with communityacquired pneumonia admitted to ICU. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya. 2007; 4 (9): 330–336 (in Russian).
Review
For citations:
Zaytsev A.A., Ovchinnikov Yu.V., Kondrat'eva T.V. An analysis of diagnostic values of prognostic tools for communityacquired pneumonia in young patients in a closed community. PULMONOLOGIYA. 2014;(5):67-72. (In Russ.) https://doi.org/10.18093/0869-0189-2014-0-5-67-72
Views:
931
Email this article 